EUVIMEDAtrasti EUVIMED
Crossref

Meflin is a marker of pancreatic stellate cells involved in fibrosis and epithelial regeneration in the pancreas

Ryota Ando, Yukihiro Shiraki iD, Yuki Miyai, Hiroki Shimizu, Kazuhiro Furuhashi, Shun Minatoguchi, Katsuhiro Kato, Akira Kato, Tadashi Iida, Yasuyuki Mizutani, Kisuke Ito, Naoya Asai and 4 more

The Journal of Pathology · 2024

DOI: 10.1002/path.6211 ↗

At a glance

Journal article in The Journal of Pathology, 2024. Written by Ryota Ando and 15 co-authors. Institution: Department of Pathology, Nagoya University Graduate School of Medicine, Nagoya, Japan. Major MEDLINE topics: Carcinoma, Pancreatic Ductal, Pancreatic Neoplasms, Pancreatitis, Chronic. Cited 14 times so far (Crossref); 59 references. Funded by: Daiko Foundation, Japan Agency for Medical Research and Development, Japan Society for the Promotion of Science.

SantraukaSubjectsBibliografiniai duomenysCiteRelated studies

Abstract (original language)

Pancreatic stellate cells (PSCs) are stromal cells in the pancreas that play an important role in pancreatic pathology. In chronic pancreatitis (CP) and pancreatic ductal adenocarcinoma (PDAC), PSCs are known to get activated to form myofibroblasts or cancer‐associated fibroblasts (CAFs) that promote stromal fibroinflammatory reactions. However, previous studies on PSCs were mainly based on the findings obtained using ex vivo expanded PSCs, with few studies that addressed the significance of in situ tissue‐resident PSCs using animal models. Their contributions to fibrotic reactions in CP and PDAC are also lesser‐known. These limitations in our understanding of PSC biology have been attributed to the lack of specific molecular markers of PSCs. Herein, we established Meflin ( Islr ), a glycosylphosphatidylinositol‐anchored membrane protein, as a PSC‐specific marker in both mouse and human by using human pancreatic tissue samples and Meflin reporter mice. Meflin‐positive (Meflin + ) cells contain lipid droplets and express the conventional PSC marker Desmin in normal mouse pancreas, with some cells also positive for Gli1, the marker of pancreatic tissue‐resident fibroblasts. Three‐dimensional analysis of the cleared pancreas of Meflin reporter mice showed that Meflin + PSCs have long and thin cytoplasmic protrusions, and are localised on the abluminal side of vessels in the normal pancreas. Lineage tracing experiments revealed that Meflin + PSCs constitute one of the origins of fibroblasts and CAFs in CP and PDAC, respectively. In these diseases, Meflin + PSC‐derived fibroblasts showed a distinctive morphology and distribution from Meflin + PSCs in the normal pancreas. Furthermore, we showed that the genetic depletion of Meflin + PSCs accelerated fibrosis and attenuated epithelial regeneration and stromal R‐spondin 3 expression, thereby implying that Meflin + PSCs and their lineage cells may support tissue recovery and Wnt/R‐spondin signalling after pancreatic injury and PDAC development. Together, these data indicate that Meflin may be a marker specific to tissue‐resident PSCs and useful for studying their biology in both health and disease. © 2023 The Pathological Society of Great Britain and Ireland.

Subjects

MeSH terms (MEDLINE)

Carcinoma, Pancreatic DuctalPancreatic NeoplasmsPancreatitis, ChronicAnimalsHumansMiceFibrosisPancreasPancreatic Stellate CellsRegenerationImmunoglobulins

Author keywords

IslrMeflincancer-associated fibroblastchronic pancreatitisfibroblastfibrosispancreaspancreatic ductal adenocarcinomapancreatic stellate cell

Substances

ISLR protein, humanImmunoglobulinsIslr protein, mouse

Authors and institutions

  • Department of Pathology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Department of Nephrology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Department of Molecular Pathology, Fujita Health University, Toyoake, Japan.
  • Division of International Center for Cell and Gene Therapy, Fujita Health University, Toyoake, Japan.
  • Center for One Medicine Innovative Translational Research, Gifu University Institute for Advanced Study, Gifu, Japan.

ORCID profiles: Yukihiro Shiraki, Shinji Mii, Masahide Takahashi, Atsushi Enomoto

Funding

  • Daiko Foundation
  • Japan Agency for Medical Research and Development
  • Japan Society for the Promotion of Science
  • Naito Foundation
  • Princess Takamatsu Cancer Research Fund
  • Takeda Science Foundation
  • Toyoaki Foundation
  • Takamatsunomiya Cancer Foundation

Cite

APA

Ando, R., Shiraki, Y., Miyai, Y., Shimizu, H., Furuhashi, K., Minatoguchi, S., Kato, K., Kato, A., Iida, T., Mizutani, Y., Ito, K., Asai, N., Mii, S., Esaki, N., Takahashi, M., & Enomoto, A. (2024). Meflin is a marker of pancreatic stellate cells involved in fibrosis and epithelial regeneration in the pancreas. The Journal of Pathology. https://doi.org/10.1002/path.6211

Vancouver

Ando R, Shiraki Y, Miyai Y, Shimizu H, Furuhashi K, Minatoguchi S, et al. Meflin is a marker of pancreatic stellate cells involved in fibrosis and epithelial regeneration in the pancreas. The Journal of Pathology. 2024. doi:10.1002/path.6211

BibTeX
@article{Ando2024,
  author = {Ando, Ryota and Shiraki, Yukihiro and Miyai, Yuki and Shimizu, Hiroki and Furuhashi, Kazuhiro and Minatoguchi, Shun and Kato, Katsuhiro and Kato, Akira and Iida, Tadashi and Mizutani, Yasuyuki and Ito, Kisuke and Asai, Naoya and Mii, Shinji and Esaki, Nobutoshi and Takahashi, Masahide and Enomoto, Atsushi},
  title = {Meflin is a marker of pancreatic stellate cells involved in fibrosis and epithelial regeneration in the pancreas},
  journal = {The Journal of Pathology},
  year = {2024},
  doi = {10.1002/path.6211}
}
Start for free →